IKK2-IN-4 (IKK2 Inhibitor VI) is a potent and selective IKK-2 inhibitor with an IC50 of 25 nM. It effectively suppresses LPS-induced TNF-alpha production in PBMCs, making it a valuable tool for studying NF-kappaB signaling in inflammatory and autoimmune disease research, both in vitro and in vivo.